Yiqi formula enhances the antitumor effects of erlotinib for treatment of triple-negative breast cancer xenografts.

MLA

Liao, Ming-Juan, et al. “Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts.” Evidence-Based Complementary and Alternative Medicine : ECAM, vol. 2014, 2014, p. 628712. EBSCOhost, https://doi.org/10.1155/2014/628712.

APA

Liao, M.-J., Ye, M.-N., Zhou, R.-J., Sheng, J.-Y., & Chen, H.-F. (2014). Yiqi formula enhances the antitumor effects of erlotinib for treatment of triple-negative breast cancer xenografts. Evidence-Based Complementary and Alternative Medicine : ECAM, 2014, 628712. https://doi.org/10.1155/2014/628712

Chicago

Liao, Ming-Juan, Mei-Na Ye, Rui-Juan Zhou, Jia-Yu Sheng, and Hong-Feng Chen. 2014. “Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts.” Evidence-Based Complementary and Alternative Medicine : ECAM 2014: 628712. doi:10.1155/2014/628712.